La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

United Orthopedic Crescita futura

Future criteri di controllo 1/6

Si prevede che United Orthopedic aumenterà i ricavi a una percentuale annua pari a 14.9%.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	20.5%
Tasso di crescita dei ricavi	15.7%
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Low
Ultimo aggiornamento	21 Aug 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

Apr 26

United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

Apr 12

What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 08

Is United Orthopedic (GTSM:4129) A Risky Investment?

Feb 16

Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

Jan 29

Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Jan 11

Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Dec 24

How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 03

Previsioni di crescita degli utili e dei ricavi

TPEX:4129 - Stime future degli analisti e dati finanziari passati (TWD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2025	5,416	N/A	401	973	2
12/31/2024	4,710	N/A	416	934	1
6/30/2024	4,275	424	-139	445	N/A
3/31/2024	4,068	407	-195	367	N/A
12/31/2023	3,930	380	-124	434	N/A
9/30/2023	3,721	342	-167	340	N/A
6/30/2023	3,546	308	-106	350	N/A
3/31/2023	3,357	252	-83	320	N/A
12/31/2022	3,169	222	-29	357	N/A
9/30/2022	2,973	173	-20	322	N/A
6/30/2022	2,832	98	106	427	N/A
3/31/2022	2,684	70	145	414	N/A
12/31/2021	2,571	29	115	342	N/A
9/30/2021	2,520	44	248	471	N/A
6/30/2021	2,551	78	256	492	N/A
3/31/2021	2,446	86	260	499	N/A
12/31/2020	2,342	78	269	501	N/A
9/30/2020	2,310	36	136	384	N/A
6/30/2020	2,240	13	64	271	N/A
3/31/2020	2,396	56	121	367	N/A
12/31/2019	2,437	84	225	519	N/A
9/30/2019	2,393	131	226	521	N/A
6/30/2019	2,327	132	-1	337	N/A
3/31/2019	2,320	116	-179	199	N/A
12/31/2018	2,332	128	-359	18	N/A
9/30/2018	2,277	100	-616	-84	N/A
6/30/2018	2,284	107	-752	-216	N/A
3/31/2018	2,187	160	N/A	-481	N/A
12/31/2017	1,973	130	N/A	22	N/A
9/30/2017	1,803	139	N/A	110	N/A
6/30/2017	1,577	106	N/A	354	N/A
3/31/2017	1,393	61	N/A	532	N/A
12/31/2016	1,383	147	N/A	183	N/A
9/30/2016	1,379	138	N/A	163	N/A
6/30/2016	1,407	186	N/A	215	N/A
3/31/2016	1,437	198	N/A	319	N/A
12/31/2015	1,393	134	N/A	253	N/A
9/30/2015	1,330	135	N/A	233	N/A
6/30/2015	1,271	113	N/A	199	N/A
3/31/2015	1,143	72	N/A	145	N/A
12/31/2014	1,101	82	N/A	93	N/A
9/30/2014	1,044	52	N/A	58	N/A
6/30/2014	997	25	N/A	6	N/A
3/31/2014	985	31	N/A	-19	N/A
12/31/2013	956	21	N/A	11	N/A
9/30/2013	935	30	N/A	84	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista 4129 è superiore al tasso di risparmio ( 1% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di 4129 cresceranno più velocemente del mercato TW

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di 4129 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di 4129 ( 14.9% all'anno) crescerà più rapidamente del mercato TW ( 11.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 4129 ( 14.9% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di 4129 è previsto essere elevato tra 3 anni

United Orthopedic Crescita futura

Future criteri di controllo 1/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target increased by 9.1% to NT$88.33

Price target decreased to NT$31.00

Recent updates

Second quarter 2024 earnings released: EPS: NT$1.06 (vs NT$0.97 in 2Q 2023)

Now 26% overvalued

United Orthopedic Corporation to Report Q2, 2024 Results on Aug 09, 2024

Upcoming dividend of NT$4.00 per share

Dividend increased to NT$4.00

United Orthopedic Corporation Announces Change in President

United Orthopedic Corporation Announces Establishment of Strategy Committee, Effective July 1, 2024

First quarter 2024 earnings released: EPS: NT$0.98 (vs NT$0.85 in 1Q 2023)

United Orthopedic Corporation to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: NT$4.50 (vs NT$2.84 in FY 2022)

United Orthopedic Corporation, Annual General Meeting, Jun 18, 2024

Investor sentiment improves as stock rises 15%

New minor risk - Shareholder dilution

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Second quarter 2023 earnings released: EPS: NT$0.97 (vs NT$0.32 in 2Q 2022)

Upcoming dividend of NT$2.28 per share at 3.0% yield

Price target increased by 9.1% to NT$88.33

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2022 earnings released: EPS: NT$2.84 (vs NT$0.37 in FY 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: NT$0.32 (vs NT$0.025 in 2Q 2021)

First quarter 2022 earnings released: EPS: NT$0.46 (vs NT$0.074 loss in 1Q 2021)

Price target decreased to NT$31.00

Less than half of directors are independent

Third quarter 2021 earnings released: EPS NT$0.05 (vs NT$0.49 in 3Q 2020)

Upcoming dividend of NT$0.84 per share

Second quarter 2021 earnings released: NT$0.04 loss per share (vs NT$0.063 profit in 2Q 2020)

First quarter 2021 earnings released: NT$0.07 loss per share (vs NT$0.17 loss in 1Q 2020)

Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

Full year 2020 earnings released: EPS NT$1.00 (vs NT$1.05 in FY 2019)

What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Is United Orthopedic (GTSM:4129) A Risky Investment?

Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

New 90-day low: NT$33.05

Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

New 90-day high: NT$36.05

How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

New 90-day high: NT$35.60

Third quarter 2020 earnings released: EPS NT$0.49

New 90-day low - NT$33.05

First half earnings released

Upcoming Dividend of NT$0.82 Per Share

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita